Table: Towa Pharmaceutical - 9-MTH group results

TOWA PHARMACEUTICAL

12/02/2020 06:00

Feb 12 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2019        Dec 31, 2018     Mar 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               84.41               78.29           111.00    
                   (+7.8 pct)          (+11.2 pct)      (+5.6 pct)  
  Operating           14.12               11.96            14.50    
                   (+18.1 pct)         (+29.8 pct)      (-9.2 pct)  
  Recurring           15.43               14.56            14.60    
                   (+6.0 pct)          (+39.1 pct)      (-22.6 pct) 
  Net                 10.97               10.46            10.40    
                   (+4.9 pct)          (+41.8 pct)      (-22.8 pct) 
  EPS              222.92 yen          212.46 yen       211.34 yen  
  EPS Diluted      206.19 yen          196.54 yen                   
  Ann Div                              107.50 yen        44.00 yen  
  -Q2 div           22.00 yen           47.50 yen                   
  -Q4 div                               60.00 yen        22.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T